<DOC>
	<DOC>NCT00857350</DOC>
	<brief_summary>HIV drug resistance presents a significant public heath problem. This proposal is designed to explore the association between ongoing illicit drug use and the prevalence of HIV drug resistance among HIV+ opioid dependent patients receiving opioid agonist treatment with the following hypotheses: 1. Hypothesis 1: The prevalence of HIV drug resistance will range between 10% and 30%. 2. Hypothesis 2: Patients with evidence of ongoing illicit drug use will be more likely to have HIV drug resistance.</brief_summary>
	<brief_title>The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>HIV Seropositivity</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<criteria>HIV+ Opioid dependent Receiving methadone or buprenorphine for at least one month age &lt; 18 years current dementia; inability to read or understand English inability to provide written informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>resistance</keyword>
	<keyword>opioid dependence</keyword>
</DOC>